A Novel Synthetic Arg-Gly-Asp-Containing Peptide Cyclo(-RGDfV-) Is the Potent Inhibitor of Angiogenesis
- 1 November 2001
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 288 (3) , 711-717
- https://doi.org/10.1006/bbrc.2001.5809
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- N-Methylated Cyclic RGD Peptides as Highly Active and Selective αVβ3Integrin AntagonistsJournal of Medicinal Chemistry, 1999
- Involvement of cholinergic processes in cholecystokinin (CCK) release by luminal oleic acidJournal of the Autonomic Nervous System, 1997
- Effects of structural modulation on biological activity of bombesin analogues with (E)-alkene bondLife Sciences, 1996
- Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3Cell, 1996
- Effect of a New Bombesin Receptor Antagonist, (E)-Alkene Bombesin Isostere, on Amylase Release from Rat Pancreatic AciniPancreas, 1995
- Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vesselsCell, 1994
- Requirement of Vascular Integrin α v β 3 for AngiogenesisScience, 1994
- Arg‐Gly‐Asp constrained within cyclic pentapoptides Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1FEBS Letters, 1991
- Tumor interactions with the vasculature: angiogenesis and tumor metastasisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1990
- Arg-Gly-Asp: A versatile cell recognition signalCell, 1986